GlomCon Hawaii is the annual conference of the GlomCon Foundation dedicated to advancing glomerular care. The conference explores the latest advancements in glomerular diseases, pathology, and treatment approaches.
Travere at GlomCon Hawaii 2025
Travere Therapeutics was excited to participate and engage with clinicians, researchers, and nephrology experts at GlomCon Hawaii 2025. We look forward to seeing you next year.
Program
Patients (Pts) With Focal Segmental Glomerulosclerosis (FSGS) Achieved Low Proteinuria Targets Earlier and More Often With Sparsentan (SPAR) vs Irbesartan (IRB) in DUPLEX
Speakers: Basmina Parmakhtiar, Vladimir Tesar, Hernán Trimarchi, James Tumlin, Laura Kooienga, Radko Komers, Jula Inrig, Edward Murphy, Eva Rodríguez García
Contact your Travere MSL
Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.
Schedule a meetingSparsentan (SPAR) Added to Stable Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in Adults With IgA Nephropathy (IgAN) in the Phase 2 SPARTACUS Trial
Speakers: Chris Gisler, Crystal Traylor, Isabelle Ayoub, Sydney CW Tang, Laura Ann Kooienga, Priscila Preciado, David S Lee, Radko Komers, Bruce Hendry, Alex Mercer, Stephanie Moody, Brad H Rovin
Urinary Biomarker Analysis Reveals Rapid Intrarenal Anti-inflammatory and Anti-fibrotic Effects of Sparsentan in IgA Nephropathy in the SPARTAN Study
Speakers: Jonathan Barratt, William A Barratt, Sulalita Chaki, Silpa Chinnakotla, Neeraj Dhaun, Siân Griffin, Bruce Hendry, Amal A A Jama, Wenjun Ju, Ishika Khan, Radko Komers, Alex Mercer, Viji Nair, Nadia Nawaz, Matthew Sayer, Smeeta Sinha, Lisa Willcocks, Matthias Kretzler, Chee Kay Cheung
MA-DS-25-0086 | September 2025